Showing 40,001 - 40,020 results of 153,975 for search '(( 2 a decrease ) OR ( 5 ((((step decrease) OR (mean decrease))) OR (teer decrease)) ))', query time: 2.29s Refine Results
  1. 40001

    An AFM tip coated with either serum-free CHO cell conditioned media (CHO), serum-free CHO conditioned media containing beta-2 myc-His ectodomain (CHO Beta-2), 100 µg/mL BSA (BSA),... by Keith H. Jansson (571788)

    Published 2014
    “…Purified beta-2 displays a 40% decrease in binding force relative to BSA (<b>A</b>) but elicits a significant increase in average binding events per engagement (<b>B</b>) and a more extensive force distribution (<b>C,D</b>) than BSA. …”
  2. 40002

    Table_1_Strategy and Performance Evaluation of Low-Frequency Variant Calling for SARS-CoV-2 Using Targeted Deep Illumina Sequencing.XLSX by Laura A. E. Van Poelvoorde (11257779)

    Published 2021
    “…<p>The ongoing COVID-19 pandemic, caused by SARS-CoV-2, constitutes a tremendous global health issue. …”
  3. 40003

    Data_Sheet_1_Strategy and Performance Evaluation of Low-Frequency Variant Calling for SARS-CoV-2 Using Targeted Deep Illumina Sequencing.pdf by Laura A. E. Van Poelvoorde (11257779)

    Published 2021
    “…<p>The ongoing COVID-19 pandemic, caused by SARS-CoV-2, constitutes a tremendous global health issue. …”
  4. 40004

    Directed evolution of HIV-1 to utilize CD4<sup>low</sup> target cells. by David Beauparlant (3491435)

    Published 2017
    “…<b>(B)</b> <u>Summary of the 18 week adaptation to low CD4 expressing target cells.</u> Stepwise decrease in available cell surface CD4 on PBMC was achieved by dose escalation of the CD4 inhibitor DARPin 57.2 (right axis, grey shaded areas). …”
  5. 40005
  6. 40006

    Effects of clinical and environmental factors on bronchoalveolar antibody responses to <i>Pneumocystis jirovecii</i>: A prospective cohort study of HIV+ patients by Robert J. Blount (292240)

    Published 2017
    “…Ambient ozone within the two weeks prior to hospital admission was associated with decreased BALF IgA responses to Msg while nitrogen dioxide was associated with increased IgA responses.…”
  7. 40007

    Quantification of GFP::2xFLAG::SEM-2 expression during M lineage development. by Marissa Baccas (20592105)

    Published 2025
    “…There is then a gradual decrease in the level of nuclear GFP::2xFLAG::SEM-2 signal in the SM descendants (D). …”
  8. 40008

    Blood markers putatively causally associated with hospitalized COVID-19. by Alish B. Palmos (5857379)

    Published 2022
    “…Using genetic instruments and under the assumptions of Mendelian randomization, six blood markers were causally associated with a significantly increased risk for hospitalization COVID-19 and nine blood markers were causally associated with a significantly decreased risk for hospitalization (q<sub>FDR</sub> ≤ 0.05). …”
  9. 40009

    The capacity to neutralize free viruses prior to completion of CD4 attachment varies across bnAb classes. by Lucia Reh (546554)

    Published 2015
    “…Data are means of two to three independent experiments. <b>C: Pre-attachment activity correlates with high potency against free virus, decreased post- attachment inhibition capacity and loss in activity during cell-cell transmission.…”
  10. 40010
  11. 40011

    Circadian properties of the mathematical model reproduce the RAS-mediated effect on the clock. by Rukeia El-Athman (4669210)

    Published 2017
    “…Module 1 consists of the INK4a/RB1/E2F1 pathway (green) and module 2 of the ARF/MDM2/p53 pathway (orange). …”
  12. 40012

    Suppression by extracellular QRNA from TNP Ts Sup free of exosomes, or miR-150 alone, associating with B-cell derived Ag-specific exosomes from the assayed CS-effector cell mixture... by Krzysztof Bryniarski (731989)

    Published 2015
    “…<u><b>b.</b></u> Similarly, two day immune B-1 B cell-derived exosomes, supplemented with decreasing doses of miR-150 alone, mediated suppression of TNP-CS-effector cell adoptive transfer (Groups E-G), down to a dose of 750pg per eventual recipient, which is 50 femtomoles per eventual recipient (Group G). …”
  13. 40013

    HCV elicits differential expression of circRNAs. by Tzu-Chun Chen (787255)

    Published 2020
    “…<p>(<b>A</b>) Experimental overview to identify HCV-induced circRNAs in infected and mock-infected cells. …”
  14. 40014
  15. 40015

    5.HT<sub>1A</sub> binding difference between known cause of death (KCOD) controls and SIDS. by Hannah C. Kinney (10280975)

    Published 2025
    “…When SIDS is compared to all KCOD controls, the HG, NTS, and MAO show a significant mean difference in 5-HT<sub>1A</sub> receptor binding. …”
  16. 40016

    datasheet1_Ozanimod for Treatment of Relapsing-Remitting Multiple Sclerosis in Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.docx by Yue Sun (197395)

    Published 2020
    “…As for the subgroup analysis, compared with 0.5 mg ozanimod, 1 mg ozanimod is related with a significant reduction of the annualized relapse rate during the treatment period (1 mg ozanimod, 0.18; 0.5 mg ozanimod, 0.24; RR, 0.05 [95% CI, 0.01, 0.09])and a decreased number of new or enlarging T2 lesions over the treatment period (1 mg ozanimod,1.58; 0.5 mg ozanimod, 2.05; RR, 0.49 [95% CI, 0.19, 0.79]). …”
  17. 40017

    datasheet1_Ozanimod for Treatment of Relapsing-Remitting Multiple Sclerosis in Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.docx by Yue Sun (197395)

    Published 2021
    “…As for the subgroup analysis, compared with 0.5 mg ozanimod, 1 mg ozanimod is related with a significant reduction of the annualized relapse rate during the treatment period (1 mg ozanimod, 0.18; 0.5 mg ozanimod, 0.24; RR, 0.05 [95% CI, 0.01, 0.09])and a decreased number of new or enlarging T2 lesions over the treatment period (1 mg ozanimod,1.58; 0.5 mg ozanimod, 2.05; RR, 0.49 [95% CI, 0.19, 0.79]). …”
  18. 40018

    Activation of autophagy via Ca<sup>2+</sup>-dependent AMPK/mTOR pathway in rat notochordal cells is a cellular adaptation under hyperosmotic stress by Li-Bo Jiang (683839)

    Published 2015
    “…However, intercellular Ca<sup>2+</sup> chelation inhibited the increase of LC3-II and partly reversed the decrease of p70S6K. …”
  19. 40019

    Image2_Alhagi maurorum extract in combination with lytic phage cocktails: a promising therapeutic approach against biofilms of multi-drug resistant P. mirabilis.JPEG by Arezoo Mirzaei (11921191)

    Published 2024
    “…The anti-biofilm effect was confirmed by Scanning Electron Microscopy (SEM). Moreover, in a bladder phantom model, there was a considerable decrease in encrustation levels compared to the control. …”
  20. 40020

    Data_Sheet_1_Case Report: Effectiveness of Targeted Treatment in a Patient With Pancreatic Cancer Harboring PALB2 Germline Mutation and KRAS Somatic Mutation.pdf by Wei Wu (27708)

    Published 2022
    “…Due to the increased CA19-9, treatment of the patient with a combination of trametinib (a MEK inhibitor) and hydroxychloroquine resulted in stable disease (SD) with a significant decrease of CA19-9. …”